Cory Nicholas is the founder of Neurona Therapeutics. Neurona Therapeutics has raised $126M in total funding. Latest round: Series B.
Cory R. Nicholas, Ph.D., is the Chief Executive Officer and Co-Founder of Neurona Therapeutics, a clinical-stage biotherapeutics company developing regenerative cell therapies for disorders of the nervous system. The company has successfully completed an upsized $102 million financing round in April 2025 and a $120 million financing round in February 2024, with proceeds used to advance its pipeline of allogeneic cell therapy candidates, including NRTX-1001 for drug-resistant mesial temporal lobe epilepsy.
Full founder directory · Investor directory · Company funding database · Fundraising library